Skip to main content
Have a personal or library account? Click to login
Growth Hormone Treatment: First Results of the Partnership Program for the Establishment of a Growth Center at the University Clinic of Pediatrics –Pleven Cover

Growth Hormone Treatment: First Results of the Partnership Program for the Establishment of a Growth Center at the University Clinic of Pediatrics –Pleven

Open Access
|Jul 2021

References

  1. 1. Haymond M, Kappelgaard AM, Czernichow P, Biller BM, Takano K, Kiess W. Early recognition of growth abnormalities permitting early intervention. Acta Paediatr, 2013;102(8):787-96.10.1111/apa.12266
  2. 2. Blizzard RM. History of growth hormone therapy. Indian J Pediatr, 2012;79(1):87-91.10.1007/s12098-011-0609-4
  3. 3. Degenerative neurologic disease in patients formerly treated with human growth hormone. Report of the Committee on Growth Hormone Use of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr, 1985;107(1):10-2.10.1016/S0022-3476(85)80604-1
  4. 4. Peneva L. Hyposomatotropism in childhood and adolescence, Dissertation, Medical Academy -Sofia, 1984;191-83.
  5. 5. Peneva L, Kazakova K, Stefanova E, Stoeva I. Treatment of children with hyposomatotropism with recombinant human growth hormone Norditropin. Paediatrics, 1996;36-41.
  6. 6. Iotova V. Effect of low weight and short stature at birth on postnatal growh and some markers of increased cardiovascular and metabolic risk in adolescents, Dissertation, Medical University -Varna, 2003.
  7. 7. Brook CGD, Clayton P, Brown R, Brook’s Clinical Pediatric Endocrinology. 2011: Wiley.10.1002/9781119968153
  8. 8. Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB et al. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Res Paediatr, 2016;86(6):361-97.10.1159/000452150
  9. 9. Iotova V. Evaluation of growth in routine outpatient and clinical settings. Paediartic practice, 2004;4:7-8.
  10. 10. Stanimirova N. Growth and development in adolescence: normal ranges and deviations. Dissertation, Medical University - Pleven, 1998.
  11. 11. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A. Body Mass Index variations: centiles from birth to 87 years. Eur. J. Clin. Nutr, 1991;45(1):13-21.
  12. 12. Darendeliler F, Lindberg A Wilton P. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency. Horm Res Paediatr, 2011;76 Suppl 1:42-6.10.1159/000329161
  13. 13. Antoniazzi F, Cavarzere P, Gaudino R. Growth hormone and early treatment. Minerva Endocrinol, 2015;40(2):129-43.
  14. 14. Rappaport R, Mugnier Е, Limoni C, Crosnier H, Czernichow P, Leger J et al. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. J. Clin. Endocrinol. Metab, 1997;82(2):452-6.
  15. 15. Stagi S, Scalini P, Farello G, Verrotti A. Possible effects of an early diagnosis and treatment in patients with growth hormone deficiency: the state of art. Ital. J. Pediatr, 2017;43(1):81.
  16. 16. Thomas M, Massa G, Craen M, de Zegher F, Bourguignon JP, Heinrichs C et al. Prevalence and demographic features of childhood growth hormone deficiency in Belgium during the period 1986-2001. Eur. J. Endocrinol, 2004;151(1):67-72.
  17. 17. Lindsay R, Feldkamp M, Harris D, Robertson, Rallison J. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J. Pediatr, 1994;125(1):29-35.10.1016/S0022-3476(94)70117-2
  18. 18. Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS et al. Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J. Clin. Endocrinol. Metab, 2013;98(6):E1072-E87.10.1210/jc.2012-3888378988623543664
  19. 19. Tsochev K, Stoycheva R, Iotova V, Karamfilova T, Markovska V, Halvadjian I et al. Results from the Implementation of a 2 Year Growth Awareness and Growth Disorders Screening Campaign (GrowInform). in 58th Annual ESPE. 2019. European Society for Paediatric Endocrinology.
  20. 20. Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab, 2006;91(10):3897-902.10.1210/jc.2006-055816849410
  21. 21. Maghnie M, Lindberg A, Koltowska-Haggstrom M Ranke MB. Magnetic resonance imaging of CNS in 15,043 children with GH deficiency in KIGS (Pfizer International Growth Database). Eur J Endocrinol, 2013;168(2):211-7.10.1530/EJE-12-080123152438
  22. 22. Collett-Solberg PF, Jorge AA, Boguszewski MC, Miller BS, Choong CSY, Cohen P et al. Growth hormone therapy in children; research and practice–A review. Growth Horm IGF Res, 2019;44:20-32.10.1016/j.ghir.2018.12.00430605792
  23. 23. Collett-Solberg PF, Ambler G, Backeljauw PF, Bidlingmaier M, Biller BMK, Boguszewski MCS et al. Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective. Horm Res Paediatr, 2019:1-14.10.1159/000502231697944331514194
  24. 24. Parra A, Argote RM, García G, Cervantes C, Alatorre S, Pérez-Pasten E. Body composition in hypopituitary dwarfs before and during human growth hormone therapy. Metab.: Clin. Exp, 1979;28(8):851-7.
  25. 25. Boot AM, Engels MA, Boerma GJ, Krenning EP de Muinck Keizer-Schrama SM. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J. Clin. Endocrinol. Metab, 1997;82(8):2423-8.
  26. 26. Carrel AL, Myers SE, Whitman BY, Eickhoff J, Allen DB. Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi syndrome. J Clin Endocrinol Metab, 2010;95(3):1131-6.10.1210/jc.2009-1389284153720061431
  27. 27. Cohen P, Bright GM, Rogol AD, Kappelgaard AM, Rosenfeld RG and A.N.C.T. Group. Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J. Clin. Endocrinol. Metab, 2002;87(1):90-8.
  28. 28. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol, 2007;157(6):695-700.10.1530/EJE-07-063118057375
  29. 29. Akaltun I, Cayir A, Kara T Ayaydin H. Is growth hormone deficiency associated with anxiety disorder and depressive symptoms in children and adolescents?: A case-control study. Growth Horm IGF Res, 2018;41:23-7.10.1016/j.ghir.2018.06.00129886327
  30. 30. Silva N, Bullinger M, Sommer R, Rohenkohl A, Witt S Quitmann J. Children’s psychosocial functioning and parents’ quality of life in paediatric short stature: The mediating role of caregiving stress. Clin Psychol Psychother, 2018;25(1):e107-e18.10.1002/cpp.214628960605
Language: English
Page range: 62 - 69
Submitted on: Jan 10, 2021
Accepted on: Apr 22, 2021
Published online: Jul 12, 2021
Published in print: Jun 1, 2021
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2021 Irina B. Halvadzhiyan, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.